BioSpace News Archive

Company Also Introduces Inaugural ‘Rare Disease Trend Report’ Providing Insights Gleaned Through Interviews and Research with Payers

Aligos Therapeutics, Inc. (Nasdaq: ALGS) today announced that it has entered into an Exclusive License and Research Collaboration Agreement with Merck, known as MSD outside the United States and Canada, under which Merck and Aligos will apply Aligos’ oligonucleotide platform technology to discover, research, optimize and develop oligonucleotides directed against a non-alcoholic steatohepatitis

The Collaboration will Accelerate the Research and Development of Next-generation Immuno-Oncology Therapies

Prof. Rathore is the first researcher in India to receive this award; he has been recognized for his contributions to biopharmaceutical research

Microbial identification has become an important aspect of the overall healthcare domain. With the growing prevalence of infectious diseases, increasing frequency of global pandemic, and rising food safety concerns the need for rapid and reliable microbial identification has become highly important.

Pyrogens are substances that lead to causing fever after administration of an injection. Rise in the body temperature and body ache are some of the prominent reactions that are caused because of injection of these harmful pyrogens in the human body.

The study confirms the potential of eryaspase as an attractive treatment option for ALL patients with hypersensitivity to PEG-asparaginase

QIAGEN N.V. announced the launch of its QuantiFERON SARS-CoV-2 RUO solution that can detect T-cell responses of the human immune system to the pathogen that causes COVID-19, which could help researchers find out more about immunity levels and disease progression.

At the Extraordinary General Meeting of BioInvent International AB on 27 November 2020, a reverse share split was resolved upon, whereby twenty-five existing shares will be consolidated into one new share.

Nordic Nanovector ASA announces that its Interim CEO, Dr Lars Nieba will present a corporate overview via live webcast at DNB’s 11th Annual Nordic Healthcare Conference, taking place on 15 December 2020.